COVID-19 vaccine manufacturing (Moderna collaboration)
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:collaboration
|
| gptkbp:beganIn |
2020
|
| gptkbp:fundedBy |
gptkb:U.S._government
gptkb:Operation_Warp_Speed |
| gptkbp:involves |
gptkb:mRNA-1273
|
| gptkbp:location |
gptkb:Europe
gptkb:United_States |
| gptkbp:output |
mRNA COVID-19 vaccines
|
| gptkbp:partner |
gptkb:Lonza_Group
gptkb:Rovi gptkb:Catalent |
| gptkbp:product |
gptkb:Spikevax
|
| gptkbp:purpose |
manufacture COVID-19 vaccines
|
| gptkbp:relatedTo |
gptkb:Moderna
gptkb:vaccine |
| gptkbp:bfsParent |
gptkb:Lonza_Group
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 vaccine manufacturing (Moderna collaboration)
|